Background {#Sec1}
==========

Obesity is an increasing challenge for public health in many countries \[[@CR1]\], and although elevated body mass index (BMI) is a modifiable risk factor for a series of metabolic disorders and chronic diseases, including insulin resistance \[[@CR2]\], metabolic syndrome, type 2 diabetes \[[@CR3]\], cardiovascular diseases (CVDs) \[[@CR2]\], hypertension \[[@CR4]\], dyslipidemia \[[@CR5]\], and certain cancers \[[@CR6]\], it is difficult to maintain weight loss. Dietary habits were considered to play a vital role in development, treatment and prevention of chronic diseases, such as obesity, hyperlipidemia, diabetes and CVDs \[[@CR7]--[@CR9]\]. Therefore, it is important to extensively focus on the associations between daily diet and chronic diseases, and reasonable dietary recommendation should be raised.

Plant sterols and plant stanols (together they are referred as phytosterols) are a group of non-nutritive but bioactive compounds naturally present in all plant origin foods, they are 28- or 29-carbon alcohols and their structures are similar to cholesterol, a 27-carbon alcohol \[[@CR10]\]. The dominant dietary plant sterols are β-sitosterol, campesterol, and stigmasterol, all have double bonds at the C-5 position of the ring. In certain structures, the double bond is saturated and these compounds are referred as plant stanols. Compared with plant sterols, concentrations of plant stanols, such as β-sitostanol and campestanol were generally lower in daily foods \[[@CR11]\]. Phytosterols are structurally similar to cholesterol and can inhibit cholesterol absorption. Many randomized controlled trials (RCTs) have confirmed that phytosterols added into fat-based foods can significantly reduce serum total cholesterol (TC) and LDL cholesterol (LDLc) \[[@CR12]--[@CR14]\]. A recent meta-analysis including 84 RCTs suggests that 2.15 g/d phytosterols added in fat matrices lowers LDLc concentration by 8.8% \[[@CR15]\]. However, daily intake of capsules containing 2 g phytosterols did not reduce total- or LDL-cholesterol significantly \[[@CR16]\], this study emphasized the importance of phytosterols from daily diets in cholesterol lowering effect.

The daily intakes of total phytosterols usually range from 200 to 400 mg in general population \[[@CR17], [@CR18]\] and higher daily intake of 500--1000 mg can be reached by vegetarians \[[@CR19], [@CR20]\]. However, in most RCTs, the health benefits are observed at a high dose of phytosterols intake (around 2 g/d), which cannot be achieved in habitual diets. In total, there are limited evidence limited evidence on the association of natural dietary intake of phytosterols and anthropometric parameters, blood glucose and serum lipid profiles. This study aims to examine the hypothesis that higher dietary phytosterols improves body weight and metabolic profile in healthy adults.

Methods {#Sec2}
=======

Internet-based FFQ {#Sec3}
------------------

In large population, food frequency questionnaires (FFQs) were universally used by researchers \[[@CR21]\]. However, impossibility of conducting traditional face-to-face FFQs during a short period make it inconvenient in researches due to time-consuming \[[@CR22]\]. Therefore, a portable tool named Internet-based dietary questionnaire for Chinese (IDQC) has been designed and validated at Harbin Medical University by experts of nutrition, epidemiology and bio-statistics \[[@CR23], [@CR24]\]. In IDQC, commonly eaten foods were divided into 16 categories (i.e., grains, potatoes, legumes, vegetables, fungus, fruits, seeds and nuts, livestock, poultry, dairy, eggs, fish, snacks, sugar, condiments, and beverages). Reference images of each food item's weight/volume were exhibited as references to assist the participants in making accurate estimation of food portions. Each participant had to choose the frequency and amount of each subtype of food groups. Finally, the questionnaires were uploaded to a secure website, which is free of access at <http://www.yyjy365.org/diet>.

Study population {#Sec4}
----------------

To restrict the cost of the biochemical measurements and the length of the study, we randomly selected 912 participants from the database of previously published literature \[[@CR25]\] (Additional file [1](#MOESM1){ref-type="media"}: Figure S1.). This sample size is sufficient to detect differences of the primary outcome between quartiles, at 95% power and 5% level of significance (0.24 mmol/l in TC and 0.24 mmol/l in LDLc). Online questionnaires including age, gender, occupation, education background, income, physical exercise, smoking, drinking and dietary habits during the past 6 months were completed by all participants as previously described \[[@CR25]\]. Daily nutrients intakes were then calculated by using the computerized China food composition tables of 2009 \[[@CR26]\].

In this study, the following exclusion criteria were applied: (1) missing data of dietary intake; (2) reported extremely low or high energy intake (i.e. \< 800 kcal (3349 kJ) or \> 5000 kcal (20,934 kJ) for males; \< 600 kcal (2512 kJ) or \> 4000 kcal (16,747 kJ) for females); (3) Diabetes diagnosis in routine physical examination; (4) Being on a diet in the past 6 months. The study complied with the Declaration of Helsinki and was approved by the Human Research Ethics Committee of the Harbin Medical University (approval code \[2015\] 006). Online informed consent was obtained from all participants.

Estimation of phytosterols intake {#Sec5}
---------------------------------

On the basis of dietary habits of Chinese residents, more than 160 types of food items (including vegetable oils, cereal and its products, beans and its products, vegetables, fruits, nuts and potatoes) in the Chinese food composition table were chosen for measurement. The contents of β-sitosterol, campesterol, stigmasterol, β-sitostanol and campestanol in food were analyzed at Institute of Nutrition and Food Safety, Chinese Centre for Disease Control and Prevention, Beijing, China, using gas chromatograph methods by Han et al. \[[@CR27], [@CR28]\]. The database of phytosterols concentrations were established and were linked to the questionnaire data, intake of phytosterols were then estimated using the IDQC. A supplementary table outlining the phytosterols contents of typical foods in Chinese was provided (Additional file [2](#MOESM2){ref-type="media"}: Table S1).

Anthropometric measurements, cut-off points of overweight/obesity and definition of abdominal obesity {#Sec6}
-----------------------------------------------------------------------------------------------------

Height, bodyweight and waist circumference (WC) were measured by well-trained medical students. Body mass index (BMI) was calculated as body weight in kilograms divided by the square of the height in meters (kg/m^2^). Participants were asked to wear light, thin clothing and no shoes. Body weight and height were measured to the nearest 0.1 kg and 0.1 cm. WC was measured midway between the lowest rib and the iliac crest with a flexible anthropometric tape on the horizontal plane with the participant in standing position, to the nearest of 0.1 cm. After a 10 min rest in a sitting position, systolic blood pressure (SBP) and diastolic blood pressure (DBP) of participants were gauged using a standard mercury sphygmomanometer by nurses of the health examination center, mean values of three times were recorded. The BMI cut-off points in Chinese subjects for overweight (24 ≤ BMI \< 28 kg/m^2^) and obesity (BMI ≥ 28 kg/m^2^) were used in our study to define these states \[[@CR29]\]. According to the 2006 Guidelines on Preservation and Control Overweight and Obesity in Chinese Adults classification \[[@CR30]\], abdominal obesity was defined as WC ≥ 85 cm in men and WC ≥ 80 cm in women.

Serum collection and laboratory measurements {#Sec7}
--------------------------------------------

Fasting blood samples were collected between 8:00 and 9:00 a.m. after fasting overnight. Then, each participant was asked to take 75 g glucose and postprandial blood samples were drawn 2 h later. FBG and 2 h-PG were measured with a hand-held glucometer (ACCU-CHEK, Roche, Shanghai, China). Blood samples were centrifuged at 3000 rpm for 15 min and the serum was used for laboratory measurements immediately. Serum triglyceride (TG), total cholesterol (TC), high density lipoprotein cholesterol (HDLc) and low density lipoprotein cholesterol (LDLc) were determined using a Roche Modular P800 Automatic Biochemical Analyzer (Roche Diagnostics, Mannheim, Germany). Coefficients of variations of lab measurements were presented in supplemental materials.

Statistical analysis {#Sec8}
--------------------

For descriptive statistics, means and SDs (or frequencies and percentages) were calculated across quartiles of dietary phytosterols and compared using one-way analysis of variance or chi-square test, as appropriate. Bivariate correlation analysis (without variants adjusted) and partial correlation analysis (with adjustment for energy intake) was performed to assess the association of dietary phytosterols and BMI, WC, SBP, DBP, FBG, 2 h-PG, serum TG, TC, HDLc and LDLc. To estimate the odds ratio (OR) and 95% confidence interval (CI) of overweight/obesity and abdominal obesity between quartiles of dietary phytosterols, logistic regression model was used. Age, education, income, labor, exercise status, smoking habits, drinking habits, dietary carbohydrate, fat, protein, cholesterol and fiber intake were adjusted in three models. The statistical analyses were carried out using SAS software (version 9.1; SAS Institute, Cary, NC, USA) and *P* \< 0.05 was considered statistically significant.

Results {#Sec9}
=======

Characteristics and dietary intakes of the study population {#Sec10}
-----------------------------------------------------------

The characteristics and dietary intakes of participants were summarized in Table [1](#Tab1){ref-type="table"}. Participants of the 3rd quartile of dietary phytosterols were youngest. Participants of the 4th quartile of dietary phytosterols had a higher percentage of low income and low education level versus the first quartile. For dietary intakes, energy, protein, fat, fiber and cholesterol intake increased through quartiles of dietary phytosterols. Finally, among individuals with higher intake of phytosterols, lower prevalence of overweight/obesity and abdominal obesity were observed.Table 1Characteristics and dietary nutrients intake of participants by quartiles (Q) of total phytosterols intakeQuartiles based on total phytosterols intakeCharacteristicsQ1Q2Q3Q4*P*Total, n228228228228Age, y32.4 ± 12.2a33.5 ± 13.1a29.4 ± 11.4b33.2 ± 12.6a0.002Gender, M/W109/11988/140106/122106/1220.179Income per month0.027 \< 2000 yuan, n (%)133 (58.3)133 (58.3)154 (67.5)158 (69.3) 2000--5000 yuan, n (%)86 (37.7)92 (40.4)70 (30.7)64 (28.1) ≥ 5000 yuan, n (%)9 (3.9)3 (1.3)4 (1.8)6 (2.6)Education\< 0.001 Under college, n (%)46 (20.2)52 (22.8)54 (23.7)72 (31.6) Bachelor, n (%)162 (71.1)166 (72.8)170 (74.5)152 (66.7) Master or doctor, n (%)20 (8.8)10 (4.4)4 (1.8)4 (1.8)PAL0.145 Light, n (%)58 (25.4)58 (25.4)58 (25.4)70 (32.5) Medium, n (%)160 (70.2)161 (70.6)168 (73.7)154 (67.5) Heavy, n (%)10 (4.4)9 (3.9)2 (0.9)4 (1.8)Exercise0.949 \< 10 h/week, n (%)101 (44.3)94 (41.2)88 (38.6)92 (40.4) 10--20 h/week, n (%)98 (43.0)104 (45.6)108 (47.4)106 (46.5) ≥ 20 h/week, n (%)29 (12.7)30 (13.2)32 (14.0)30 (13.2)Smoking^a^0.072 Non-smoker, n (%)206 (90.4)207 (90.8)210 (92.1)194 (85.1) Current smoker, n (%)22 (9.6)21 (9.2)18 (7.9)34 (14.9)Drinking^a^0.636 Non-drinker, n (%)182 (79.8)184 (80.7)184 (80.7)192 (84.2) Current drinker, n (%)46 (20.2)44 (19.3)44 (19.3)36 (15.8)Overweight/obesity, n (%)100 (43.9)90 (39.5)82 (36.0)74 (32.5)0.075Abdominal obesity, n (%)77 (33.8)62 (27.2)59 (25.9)54 (23.7)0.092Dietary intakes Energy, kcal2179.3 ± 528.7a2271.9 ± 551.5b2368.9 ± 548.6c2498.2 ± 494.1d\< 0.001 Protein, g/d76.1 ± 21.2a82.9 ± 23.9b86.9 ± 24.9b95.2 ± 22.1c\< 0.001 Fat, g/d60.2 ± 23.0a69.5 ± 23.7b74.3 ± 24.7c86.4 ± 21.7d\< 0.001 Carbohydrate, g/d344.9 ± 93.6343.6 ± 89.9353.0 ± 91.7355.8 ± 89.80.399 Fiber, g/d14.4 ± 3.9a17.3 ± 4.4b19.5 ± 4.9c23.1 ± 5.2d\< 0.001 Cholesterol, mg/d382.9 ± 230.5a461.1 ± 266.9b445.8 ± 275.0b504.2 ± 260.4c\< 0.001 Total plant sterols, mg/d161.9 ± 23.0231.3 ± 20.1294.0 ± 18.8383.0 ± 54.4\< 0.001 β-sitosterol, mg/d96.4 ± 16.8a139.9 ± 22.2b187.9 ± 27.9c255.7 ± 47.3d\< 0.001 campesterol, mg/d32.5 ± 13.4a48.8 ± 20.4b51.4 ± 26.9b57.9 ± 29.2c\< 0.001 stigmasterol, mg/d12.5 ± 5.4a15.0 ± 5.9b17.8 ± 7.5c19.0 ± 7.3d\< 0.001 β-sitostanol, mg/d9.2 ± 4.4a13.3 ± 5.6b18.5 ± 6.6c27.2 ± 7.5d\< 0.001 campestanol, mg/d11.3 ± 3.3a14.4 ± 4.0b18.3 ± 4.2c23.2 ± 4.8d\< 0.001*P* values are for differences across quartiles of total plant sterols intake; Data are mean ± SD or frequency (percentage), a, b, c, d, mean values with unlike letters were significantly different (*P* \< 0.05)Abbreviations: *PAL* physical activity level^a^ There is no report of quitting smoking or quitting drinking in our population

Anthropometric parameters, blood glucose and serum lipid profiles of participants {#Sec11}
---------------------------------------------------------------------------------

BMI, WC, blood glucose and serum lipid profiles of participants among quartiles of dietary phytosterols were showed in Table [2](#Tab2){ref-type="table"}. Compared with those in the first quartile of dietary phytosterols, participants of the 4th quartile had lower BMI, WC, SBP, DBP, TC and LDLc (*P* \< 0.01 for BMI and TC, *P* \< 0.05 for WC, SBP, DBP and LDLc). After stratified by gender, similar results were observed in men and women (all *P* \< 0.05). There is no significant difference of FBG, 2 h-PG, TG and HDLc among quartiles of dietary phytosterols.Table 2Anthropometric parameters, blood glucose and serum lipid profiles of participants by quartiles (Q) of total phytosterols intakeQuartiles based on total phytosterols intakeQ1Q2Q3Q4*P*Overall, n228228228228 BMI, kg/m^2^23.85 ± 3.1723.53 ± 3.4423.05 ± 3.71^\*^22.67 ± 2.76^\*\*^0.001 WC, cm80.31 ± 10.2178.76 ± 8.7478.45 ± 9.67^\*^78.12 ± 7.91^\*^0.044 SBP, mm Hg119.51 ± 11.16117.13 ± 12.42116.45 ± 11.33115.04 ± 10.14^\*^0.034 DBP, mm Hg78.74 ± 8.9277.32 ± 8.4176.72 ± 8.9376.27 ± 7.22^\*^0.046 FBG, mmol/l4.71 ± 0.814.68 ± 0.734.59 ± 0.824.62 ± 0.780.282 2 h-PG, mmol/l6.42 ± 0.976.35 ± 0.816.33 ± 0.876.27 ± 0.960.361 TG, mmol/l1.68 ± 1.241.73 ± 1.311.71 ± 1.281.75 ± 1.380.916 TC, mmol/l5.25 ± 0.875.17 ± 0.785.09 ± 0.865.01 ± 0.90^\*\*^0.004 HDLc, mmol/l1.26 ± 0.331.25 ± 0.341.29 ± 0.291.25 ± 0.360.289 LDLc, mmol/l2.55 ± 0.832.42 ± 0.862.39 ± 0.792.31 ± 0.90^\*^0.042Men, n102102102103 BMI, kg/m^2^23.91 ± 3.0923.77 ± 3.2523.41 ± 3.3622.75 ± 2.68^\*^0.016 WC, cm83.45 ± 9.2681.19 ± 9.6279.63 ± 9.18^\*^78.58 ± 7.26^\*^0.024 SBP, mm Hg120.12 ± 12.01118.03 ± 11.45117.17 ± 11.45115.03 ± 9.98^\*^0.047 DBP, mm Hg79.11 ± 7.9278.23 ± 8.6377.87 ± 8.9577.03 ± 7.15^\*^0.045 FBG, mmol/l4.75 ± 0.864.81 ± 0.784.79 ± 0.814.72 ± 0.910.442 2 h-PG, mmol/l6.51 ± 0.926.66 ± 0.986.35 ± 0.786.24 ± 0.860.296 TG, mmol/l1.79 ± 1.141.73 ± 1.211.78 ± 1.241.76 ± 1.410.855 TC, mmol/l5.17 ± 0.915.06 ± 0.895.01 ± 0.814.95 ± 0.88^\*^0.028 HDLc, mmol/l1.27 ± 0.351.26 ± 0.381.24 ± 0.321.23 ± 0.370.354 LDLc, mmol/l2.44 ± 0.862.31 ± 0.912.25 ± 0.772.19 ± 0.86^\*^0.034Women, n125126126126 BMI, kg/m^2^23.72 ± 3.2423.41 ± 3.3122.78 ± 3.74^\*^22.45 ± 2.66^\*^0.021 WC, cm76.02 ± 8.1774.28 ± 8.2173.20 ± 9.12^\*^72.89 ± 7.31^\*^0.047 SBP, mm Hg118.23 ± 10.93116.34 ± 12.78114.96 ± 11.61113.82 ± 10.21^\*^0.038 DBP, mm Hg77.71 ± 8.8676.25 ± 8.5275.12 ± 8.6174.78 ± 7.31^\*^0.032 FBG, mmol/l4.68 ± 0.824.59 ± 0.714.41 ± 0.784.44 ± 0.980.341 2 h-PG, mmol/l6.31 ± 0.916.26 ± 0.956.31 ± 0.826.33 ± 0.910.458 TG, mmol/l1.58 ± 1.311.72 ± 1.341.66 ± 1.221.74 ± 1.330.545 TC, mmol/l5.34 ± 0.765.29 ± 0.765.18 ± 0.925.06 ± 0.93^\*^0.013 HDLc, mmol/l1.24 ± 0.321.24 ± 0.311.33 ± 0.291.27 ± 0.360.128 LDLc, mmol/l2.67 ± 0.812.52 ± 0.832.46 ± 0.812.41 ± 0.85^\*^0.044Abbreviations: *BMI* body mass index, *WC* waist circumference, *SBP* systolic blood pressure, *DBP* diastolic blood pressure, *FBG* fasting blood glucose, *2 h-PG* 2 h-postprandial glucose, *TG* triglyceridel, *TC* total cholesterol, *HDLc* high destiny lipoprotein cholesterol, *LDLc* low destiny lipoprotein cholesterol\* *P* \< 0.05; \*\* *P* \< 0.01 compared with the 1st quartile

Correlations between dietary phytosterols and anthropometric parameters, blood glucose and serum lipid profiles {#Sec12}
---------------------------------------------------------------------------------------------------------------

As shown in Table [3](#Tab3){ref-type="table"}, we found negative correlations between total phytosterols and BMI, WC, SBP, DBP, TC and LDLc (all *P* \< 0.05). The associations were stronger with adjustment of total energy intake. After stratified by gender, similar trends were observed in male and female (all *P* \< 0.05). However, no significant associations between dietary phytosterols and FBG, 2 h-PG, TG and HDLc were observed.Table 3Correlation analysis of dietary total phytosterols versus anthropometric parameters, blood glucose and serum lipid profilesTotal phytosterols intake, mg/dUnadjustedAdjusted^a^*rPrP*Overall BMI, kg/m^2^−0.181\< 0.001− 0.226\< 0.001 WC, cm− 0.1060.001− 0.167\< 0.001 SBP, mm Hg− 0.112\< 0.001− 0.132\< 0.001 DBP, mm Hg− 0.1090.002−0.134\< 0.001 FBG, mmol/l−0.024NS−0.033NS 2 h-PG, mmol/l−0.019NS−0.023NS TG, mmol/l−0.033NS−0.041NS TC, mmol/l−0.144\< 0.001−0.183\< 0.001 HDLc, mmol/l−0.023NS−0.029NS LDLc, mmol/l−0.138\< 0.001−0.167\< 0.001Men BMI, kg/m^2^−0.212\< 0.001−0.243\< 0.001 WC, cm−0.164\< 0.001−0.206\< 0.001 SBP, mm Hg−0.1170.024−0.1360.011 DBP, mm Hg−0.1120.031−0.1400.023 FBG, mmol/l−0.028NS−0.037NS 2 h-PG, mmol/l−0.023NS−0.029NS TG, mmol/l−0.034NS−0.044NS TC, mmol/l−0.1470.003−0.191\< 0.001 HDLc, mmol/l−0.021NS−0.023NS LDLc, mmol/l−0.1330.006−0.185\< 0.001Women BMI, kg/m^2^−0.158\< 0.001−0.210\< 0.001 WC, cm−0.0870.047−0.1220.006 SBP, mm Hg−0.1060.028−0.1290.011 DBP, mm Hg−0.1050.042−0.1190.033 FBG, mmol/l−0.019NS−0.024NS 2 h-PG, mmol/l−0.014NS−0.018NS TG, mmol/l−0.029NS−0.031NS TC, mmol/l−0.1370.011−0.179\< 0.001 HDLc, mmol/l−0.027NS−0.033NS LDLc, mmol/l−0.1210.021−0.1450.006Abbreviations: *BMI* body mass index, *WC* waist circumference, *SBP* systolic blood pressure, *DBP* diastolic blood pressure, *FBG* fasting blood glucose, *2 h-PG* 2 h-postprandial glucose, *TG* triglyceride, *TC* total cholesterol, *HDLc* high destiny lipoprotein cholesterol, *LDLc* low destiny lipoprotein cholesterol, *NS* no significance^a^ Adjusting for total energy intake

Correlations between dietary plant sterols and prevalence of obesity {#Sec13}
--------------------------------------------------------------------

With adjustment for potential dietary and non-dietary cofounders (age, education, income, PAL, physical exercise, smoking and drinking status, dietary carbohydrate, fat, protein, fiber and cholesterol intake), we found higher dietary total phytosterols intake was linked with lower prevalence of overweight/obesity. Data was illustrated in Table [4](#Tab4){ref-type="table"}, compared with the 1st quartile, the multivariable-adjusted ORs of overweight/obesity of the 4th quartile were 0.440 (0.254, 0.763) in overall population, 0.487 (0.234, 0.918) in men and 0.277 (0.124, 0.619) in women. (All *P* \< 0.05).Table 4Association between total phytosterols intake and prevalence of overweight/obesityOverallQ1Q2Q3Q4 Participants, n228228228228 No. of cases, n100908274 Intake, mg/d161.9231.3294383Crude10.835 (0.575, 1.212)0.719 (0.493, 1.047)0.615 (0.420, 0.900)^\*^ Model 110.746 (0.496, 1.122)0.762 (0.504, 1.151)0.496 (0.324, 0.761)^\*\*^ Model 210.708 (0.462, 1.085)0.711 (0.445, 1.136)0.440 (0.254, 0.763)^\*\*^MenQ1Q2Q3Q4 Participants, n102102102103 No. of cases, n49443432 Intake, mg/d157.3233381.4301 Crude10.835 (0.480, 1.451)0.541 (0.307, 0.952)^\*^0.481 (0.272, 0.850)^\*^ Model 110.752 (0.412, 1.373)0.552 (0.294, 1.035)0.509 (0.274, 0.946)^\*^ Model 210.778 (0.403, 1.501)0.559 (0.244, 1.183)0.487 (0.234, 0.918)^\*^WomenQ1Q2Q3Q4 Participants, n125126126126 No. of cases, n52514242 Intake, mg/d165.6229.3287.6384.2 Crude0.955 (0.577, 1.579)0.702 (0.420, 1.173)0.702 (0.420, 1.173) Model 10.927 (0.527, 1.631)0.790 (0.441, 1.414)0.501 (0.275, 0.911)^\*^ Model 210.758 (0.416, 1.380)0.537 (0.275, 1.048)0.277 (0.124, 0.619)^\*\*^Model 1: adjusting for age, education, income, PAL, exercise status, smoking and drinking habitsModel 2: Model 1 + dietary carbohydrate, fat, protein, fiber and cholesterol intake were adjusted\* *P* \< 0.05; \*\* *P* \< 0.01 compared with the 1st quartile

Correlations between dietary plant sterols and prevalence of abdominal obesity {#Sec14}
------------------------------------------------------------------------------

In this study, we have observed the reverse relationship between dietary phytosterols and abdominal obesity. As shown in Table [5](#Tab5){ref-type="table"}, compared with the 1st quartile, the multivariable-adjusted ORs of abdominal obesity of the 4th quartile were 0.239 (0.127, 0.450); 0.344 (0.144, 0.819) and 0.321 (0.140, 0.571) in overall population, men and women, respectively (All *P* \< 0.05). Potential dietary and non-dietary cofounders (age, education, income, PAL, physical exercise, smoking and drinking status, dietary carbohydrate, fat, protein, fiber and cholesterol intake) were rectified.Table 5Association between total phytosterols intake and prevalence of abdominal obesityOverallQ1Q2Q3Q4 Participants, n228228228228 No. of cases, n77625954 Intake, mg/d161.9231.3294383 Crude10.732 (0.491, 1.093)0.685 (0.457, 1.025)0.609 (0.404, 0.918)^\*^ Model 110.806 (0.513, 1.266)0.566 (0.360, 0.891)^\*^0.490 (0.305, 0.785)^\*\*^ Model 210.512 (0.302, 0.868)^\*^0.423 (0.259, 0.691)^\*\*^0.239 (0.127, 0.450)^\*\*^MenQ1Q2Q3Q4 Participants, n102102102103 No. of cases, n51433636 Intake, mg/d157.3233381.4301 Crude10.741 (0.426, 1.289)0.529 (0.302, 0.927)^\*^0.545 (0.311, 0.957)^\*^ Model 110.657 (0.355, 1.215)0.520 (0.303, 0.955)^\*^0.510 (0.293, 0.951)^\*^ Model 210.462 (0.233, 0.918)^\*^0.407 (0.191, 0.864)^\*^0.344 (0.144, 0.819)^\*^WomenQ1Q2Q3Q4 Participants, n125126126126 No. of cases, n25232018 Intake, mg/d165.6229.3287.6384.2 Crude10.893 (0.476, 1.676)0.755 (0.395, 1.443)0.667 (0.343, 1.295) Model 110.738 (0.354, 1.539)0.672 (0.305, 1.480)0.341 (0.151, 0.770)^\*^ Model 210.525 (0.216, 1.276)0.497 (0.221, 1.118)0.321 (0.140, 0.571)^\*\*^Model 1: adjusting for age, education, income, PAL, exercise status, smoking and drinking habitsModel 2: Model 1 + dietary carbohydrate, fat, protein, fiber and cholesterol intake were adjusted\* *P* \< 0.05; \*\* *P* \< 0.01 compared with the 1st quartile

Discussion {#Sec15}
==========

To our knowledge, this is the first Internet-based cross-sectional study to investigate associations between dietary phytosterols and anthropometric parameters, blood glucose, serum lipid profiles and prevalence of overweight/obesity and abdominal obesity among healthy subjects. The major finding of this study is that higher dietary phytosterols intake was associated with lower BMI, WC, blood pressure, serum TC and LDLc and lower prevalence of overweight/obesity and abdominal obesity in northern Chinese adults. A moderate dietary intake of total plant sterols was found (267.5 mg/d) in our population. Therefore, this sample can represent the general population.

Lifestyle, including dietary habits and physical exercises, could present a distinct effect on management of bodyweight and lipid/lipoprotein. Here, we generally found a dose-dependent inverse association between phytosterols intake from natural diet and BMI, WC, blood pressure, TC and LDLc in northern Chinese adults. Our findings suggest that higher intake of phytosterols in natural diet may be favorable in the prevention of overweight/obesity and improve cholesterol metabolism. Therefore, reasonable advice of consuming more phytosterol-rich foods may be useful for these patients.

It has been established that high dose of phytosterols can significantly reduce blood cholesterol in RCTs \[[@CR31]\]. However, it was still undecided whether low doses of phytosterols from natural diets were effective in management of serum cholesterol. In our reserch, we found that higher dietary phytosterols were related with lower serum TC and LDLc after adjustment for total energy intake. Similar results were observed in two large cross-sectional studies. In the European Prospective Investigation into Cancer and Nutrition (EPIC-Norfolk) study, a 289 mg/d or 281 mg/d (in men/women) increase of phytosterols intake was correlated to 4.1%/2.4% decrease in serum TC and 3.5%/3.0% decrease in LDLc, respectively \[[@CR32]\]. Another study including 37,150 men and 40,502 women presents 2.6%/3.5% lower TC and 3.1%/3.2% lower LDLc in highest quintile in comparison with the lowest quintile of plant sterols in men and women, respectively \[[@CR33]\].

The underlying mechanism of hypocholesterolemic activity of phytosterols was summarized in a recent review \[[@CR34]\]. It is well accepted that phytosterols inhibit the intestinal absorption of dietary cholesterol due to their greater affinity for micelles \[[@CR35]\]. Therefore, more cholesterol and its metabolites were excreted by feces. Recent studies also suggest that phytosterols might lower LDLc by upregulating intestinal cholesterol efflux transporters and receptor-mediated lipoprotein cholesterol uptake in response to the reduced supply of exogenous cholesterol \[[@CR34]\]. Moreover, in high fat diet feeding hamsters, phytosterols supplementation leads to a remarkable increase in the biliary bile acid:cholesterol ratio, induces the expression of CYP7A1, which governs the synthesis of bile acid and controls its activity at the transcriptional level \[[@CR36]\], and normalizes the expression of HNF4A, a key controller of bale acid metabolism \[[@CR37], [@CR38]\], indicating that phytosterols enhance bile acid synthesis.

Another important finding of this study was the lower SBP and DBP of the 4th quartile of dietary phytosterols than in the 1st quartile. The lower SBP was most likely interpreted by the lower body weight. The benefits of the decrease in blood pressure are apparent, because lower blood pressure has been shown to lower risk of cardiovascular morbidity \[[@CR39]\]. Coker et al. reported that dietary supplementation of essential amino acids and phytosterols may reduce risk for metabolic syndrome and cardiovascular diseases by promoting the reductions of blood lipids and improving insulin resistance in overweight individuals with hypertriglyceridemia \[[@CR40]\]. In our work, we did not observe significant correlations in FBG or 2 h-PG because, at least in part, diabetic patients were excluded from the study, and both FBG and 2 h-PG were in normal ranges at baseline.

The major limitation of this study is the cross-sectional and retrospective design which might have limitations in the confirmation of causal relationship. Therefore, long term cohort studies for verification of this issue are needed. Secondly, we included only those subjects who lived in Harbin, in consideration of the large population and vast territory of China, we should be rigorous to extrapolate this result to the general population.

In spite of those defects, this is the first web-based FFQ study that has investigated this issue. In our previous study, there were significantly positive correlations in the dietary intakes of 9 food groups and 23 nutrients between the IDQC and 3-day diet records \[[@CR24]\], these data suggested that the intake of phytosterols assessed by using IDQC might reflect a long-term and stable habitual intake of phytosterols from habitual diets in this population. We firstly reported that higher dietary phytosterols were associated with lower BMI, WC, blood pressure, serum TC and LDLc and lower prevalence of overweight/obesity and abdominal obesity, which provided practical significances in nutritional counseling as the importance for prevention of dyslipidemia, obesity and cardiovascular diseases. For overweight/obese and hypercholesterolemia clients, advice of consuming more plant sterols-rich foods may be useful.

Conclusions {#Sec16}
===========

Overall, our study firstly reported that dietary phytosterols were negatively associated with BMI, WC, SBP, DBP, serum TC and LDLc. Higher dietary phytosterols were also associated with lower prevalence of overweight/obesity and abdominal obesity. Further studies are needed to verify the causal association and explore the potential mechanism.
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2 h-PG

:   2 h-postprandial glucose

BMI

:   Body mass index

CI

:   Confidence interval

CVDs

:   Cardiovascular diseases

DBP

:   Diastolic blood pressure

FBG

:   Fasting blood glucose

FFQ

:   Food frequency questionnaire

HDLc

:   High density lipoprotein cholesterol

IDQC

:   Internet-based dietary questionnaire for Chinese

LDLc

:   Low density lipoprotein cholesterol

OR

:   Odds ratio

RCTs

:   Randomized controlled trials

SBP

:   Systolic blood pressure

TC

:   Total cholesterol

TG

:   Triglycerides
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:   Waist circumference
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